Immunization, Vaccines and Biologicals

WHO/IVB/11.07

Intermittent Preventive Treatment for Infants Using Sulfadoxine-Pyrimethamine (SP-IPTi) for Malaria Control in Africa: An Implementation Field Guide

SP-IPTi is the administration of a full therapeutic course of sulfadoxine-pyrimethamine (SP) delivered through the Expanded Programme on Immunization (EPI) at intervals corresponding to routine vaccination schedules for the second and third doses of DTP/Penta, and measles vaccination -- usually at 8-10 weeks, 12-14 weeks, and ~9 months of age -- to infants at risk of malaria in Sub-Saharan Africa. This implementation guide provides the necessary technical and operational information and tools for country-level policy-makers and programme managers to decide on how to include SP-IPTi with immunization services. This practical "how to" guide draws upon the experience and lessons learned from pilot implementation projects in Benin, Ghana, Madagascar, Malawi, Mali, Senegal and Tanzania.

Size: 2.5 MB

Share